Metraipolis › archive › dc_382f6bfa9282
Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine — Europe PMC PMID:39771605
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/39771605
- DOI
- 10.3390/pharmaceutics16121627
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T19:25:25.335Z
- SHA-256 of the archived text
efd11abc98f5e2097c305ecaa8859e9efbf992aa37d5382cca31a732fa8827d5- Stable URL of this page
https://metraipolis.com/documento/dc_382f6bfa9282
How to cite
Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine — Europe PMC PMID:39771605 — Europe PMC (en), https://europepmc.org/article/MED/39771605 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_382f6bfa9282 (Metraipolis archive dc_382f6bfa9282, sha256 efd11abc98f5e2097c305ecaa8859e9efbf992aa37d5382cca31a732fa8827d5)
BibTeX
@misc{dc382f6bfa9282,
title = {Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine — Europe PMC PMID:39771605},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/39771605},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_382f6bfa9282; sha256 efd11abc98f5e2097c305ecaa8859e9efbf992aa37d5382cca31a732fa8827d5},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39771605. Agents can read the archived copy with the MCP tool read_document.